Jan Groen

Chief Executive Officer & Director at Novigenix SA

Jan Groen

Jan Groen

Chief Executive Officer & Director at Novigenix SA

Overview
Career Highlights

Agendia NV
Agendia, Inc.
Novigenix SA

RelSci Relationships

288

Number of Boards

6

Birthday

1959

Age

61

Relationships
RelSci Relationships are individuals Jan Groen likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Director at Eagle NV

Relationship likelihood: Strong

Executive Chairman & Co-Chief Executive Officer at MyCartis NV

Relationship likelihood: Strong

Chief Executive Officer at Camel-IDS NV

Relationship likelihood: Strong

Former Vice President & General Manager-Critical Care Products at Abbott Laboratories

Relationship likelihood: Strong

Chief Executive Officer & Executive Director at MDxHealth SA

Relationship likelihood: Strong

Chief Executive Officer at Immunotope, Inc.

Relationship likelihood: Strong

Chief Executive & Investment Officer at Valiance Asset Management Ltd.

Relationship likelihood: Strong

Director at Materialise NV

Relationship likelihood: Strong

Managing Partner at SALUS Partners SA

Relationship likelihood: Strong

Vice President at Abbott Nutrition Manufacturing, Inc.

Relationship likelihood: Strong

Paths to Jan Groen
Potential Connections via
Relationship Science
You
Jan Groen
Chief Executive Officer & Director at Novigenix SA
Education
Doctorate Degree

Erasmus Universiteit Rotterdam

Career History
Chief Executive Officer & Director
2019 - Current

Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland.

President & Chief Executive Officer
2010 - 2019

MDxHealth SA engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, The Netherlands, Belgium, Spain, Poland, Italy, Rest of EU, and Rest of the World. It offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.

President
Prior

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia's tests can help physicians assess a patient's individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and René Bernards in 2003 and is headquartered in Irvine, CA.

Boards & Committees
Member, Supervisory Board
Prior

IBL International engages in the development, production and worldwide distribution of in-vitro diagnostic test systems for routine and research use. With more than 25 years of experience IBL is experts in enzyme, radio, and luminescence immunoassays.IBL provides a very extensive range of products for special diagnostics. Most products are designed for manual use, but also readily adaptable for use in open automated systems.IBL offers a broad range of products for specific applications. Most of the products are designed for manual use, but can also be adapted for uses on open automate systems.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jan Groen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jan Groen's profile does not indicate a business or promotional relationship of any kind between RelSci and Jan Groen.